Progressive Pulmonary Fibrosis in Hamsters

References

• Carrington C B. Organizing interstitial pneumonia. Definition of the lesion and attempts to devise an experimental model. Yale J Biol Med 1968; 40: 352–363
   PubMed Web of Science ®Google Scholar
• Richerson H B, Seidenfeld J J, Ratajczak H V, et al. Models of pulmonary fibrosis. Misadventures and ramifications. Chest 1979; 75(Suppl)267–269
   PubMedGoogle Scholar
• Snider G L, Celli B R, Goldstein R H, Hayes J A. Endotracheal bleomycin in hamsters: A model of interstitial pulmonary fibrosis. Am Rev Respir Dis 1977; 115(Suppl)245
   PubMedGoogle Scholar
• Raisfeld I H. Pulmonary toxicity of bleomycin analogs. Toxicol Appl Pharmacol 1980; 56: 326–336
   PubMed Web of Science ®Google Scholar
• Starcher B C, Kuhn C, Overton J E. Increased elastin and collagen content in the lungs of hamsters receiving an intratracheal injection of bleomycin. Am Rev Respir Dis 1978; 117: 299–305
   PubMed Web of Science ®Google Scholar
• Goldstein R H, Lucey E C, Franzblau C, Snider G L. Failure of mechanical properties to parallel changes in lung connective tissue composition in bleomycin induced pulmonary fibrosis in hamsters. Am Rev Respir Dis 1979; 120: 67–73
   PubMed Web of Science ®Google Scholar
• Hesterberg T W, Gerriets J E, Reiser K M, et al. Bleomycin-induced pulmonary fibosis: Correlation of biochemical, physiological and histological changes. Toxicol Appl Pharmacol 1981; 60: 360–367
   PubMed Web of Science ®Google Scholar
• Karlinsky J B, Goldstein R H. Fibrotic lung disease—A perspective. J Lab Clin Med 1980; 96: 939–942
   PubMed Web of Science ®Google Scholar
• Thrall R S, Phau S H, McCormick J R, Ward P A. The development of bleomycin induced pulmonary fibrosis in neutrophil-depleted and complement-depleted rats. Am J Pathol 1981; 105: 76–81
   PubMed Web of Science ®Google Scholar
• Riley D J, Kerr J S, Berg R A, et al. Beta-aminoproprionitrile prevents bleomycin-in-duced pulmonary fibrosis in the hamster. Am Rev Respir Dis 1982; 125: 67–73
   PubMed Web of Science ®Google Scholar
• Collins J F, Orozco C R, McCullough B, et al. Pulmonary fibrosis with small airway disease: A model in non-human primates. Exp Lung Res 1982; 3: 91–108
   PubMed Web of Science ®Google Scholar
• Tryka A F, Skornik W A, Godleski J J, Brain J D. Potentiation of bleomycin induced lung injury by exposure to 70% oxygen. Morphologic assessment. Am Rev Respir Dis 1982; 126: 1074–1079
   PubMed Web of Science ®Google Scholar
• Snider G L, Hayes J A, Korthy A L. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Am Rev Respir Dis 1978; 117: 1099–1108
   PubMed Web of Science ®Google Scholar
• Fisher H K, Clements J A, Wright R R. Enhancement of oxygen toxicity by the herbicide paraquat. Am Rev Respir Dis 1973; 107: 246–252
   PubMed Web of Science ®Google Scholar
• Deneke S M, Bernstein S P, Fanburg B L. Enhancement by disulfiram (Antabuse) of toxic effects of 95 to 97% O2 on the rat lung. J Pharmacol Exp Ther 1979; 208: 377–380
   PubMed Web of Science ®Google Scholar
• Witschi H R, Haschek W M, Klein-Szanto A JP, Hakkinen P J. Potentiation of diffuse lung damage by oxygen: Determining variables. Am Rev Respir Dis 1981; 123: 98–103
   PubMed Web of Science ®Google Scholar
• Rinaldo J E, Goldstein R H, Snider G L. The toxicity of oxygen in hamsters with bleo-mycin-induced interstitial pneumonia. Am Rev Respir Dis 1980; 121(Suppl)183, (abstr)
   Google Scholar
• Tryka A F, Godleski J J, Skornik W A, Brain J D. Bleomycin and 70% oxygen exposure; early and late effects. Am Rev Respir Dis 1982; 125(Suppl)92, (abstr)
   Google Scholar
• Toledo C H, Ross W E, Hood C I, Block E R. Potentiation of bleomycin toxicity by oxygen. Cancer Treat Rep 1982; 66: 359–362
   PubMedGoogle Scholar
• Hakkinen P J, Whiteley J W, Witschi H R. Hyperoxia, but not thoracic x-irradiation, potentiates bleomycin and cyclophosphamide-induced lung damage in mice. Am Rev Respir Dis 1982; 126: 281–285
   PubMed Web of Science ®Google Scholar
• Brain J D, Knudsen D E, Sorokin S P, Davis M A. Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation. Environ Res 1976; 11: 13–33
   PubMed Web of Science ®Google Scholar
• Hayatdavoudi G, Crapo J D, Miller F J, O'Neil J J. Factors determining degree of inflation in intratracheally fixed rat lungs. J Appl Physiol Respir Environ Exercise Physiol 1980; 48: 389–393
   PubMed Web of Science ®Google Scholar
• Weibel E R. Stereological Methods. Practical Methods for Biological Morphometry. Academic Press, London 1979; Vol 1
   Google Scholar
• Pratt P C, Vollmer R T, Shelburne J D, Crapo J D. Pulmonary morphology in a multihospital collaborative extracorporeal membrane oxygenation project. Am J Pathol 1979; 95: 191–214
   PubMed Web of Science ®Google Scholar
• Skornik W A, Heimann R, Jaeger R J. Pulmonary mechanics in guinea pigs: Repeated measurements using a nonsurgical computerized method. Toxicol Appl Pharmacol 1981; 59: 314–323
   PubMed Web of Science ®Google Scholar
• Nash G, Blennerhassett J B, Pontoppidan H. Pulmonary lesions associated with oxygen therapy and artificial ventilation. N Engl J Med 1967; 276: 368–374
   PubMed Web of Science ®Google Scholar
• Crystal R G, Gadek J E, Ferrans V J, et al. Interstitial lung disease: Current concepts of pathogenesis, staging and therapy. Am J Med 1981; 70: 542–568
   PubMed Web of Science ®Google Scholar
• Carrington C B, Gaensler E A, Coutu R E, et al. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978; 298: 801–809
   PubMed Web of Science ®Google Scholar
• Lourenco R V, Turino G M, Davidson L AG, Fishman A P. The regulation of ventilation in diffuse pulmonary fibrosis. Am J Med 1965; 38: 199–215
   PubMed Web of Science ®Google Scholar
• Fulmer J D, Roberts W C, VonGal E R, Crystal R G. Morphologic—physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. J Clin Invest 1979; 63: 665–676
   PubMed Web of Science ®Google Scholar
• Fulmer J D, Bienkowski R S, Cowan M J, et al. Collagen concentration and rates of synthesis in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1980; 122: 289–301
   PubMed Web of Science ®Google Scholar
• Liebow A A. Definition and classification of interstitial pneumonias in human pathology. Alveolar Interstitium of the Lung. Pathological and Physiological Aspects. Progress in Respiration Research, F Basset, R Georges. Karger, Basel 1975; Vol 8
   Google Scholar
• Trush M A, Mimnaugh E G, Ginsburg E, Gram T E. Studies on the interaction of bleomycin A2 with rat lung microsomes. I. Characterization of factors which influence bleo-mycin-mediated DNA chain breakage. J Pharmacol Exp Ther 1982; 221: 152–158
   PubMed Web of Science ®Google Scholar
• Deneke S M, Fanburg B L. Normobaric oxygen toxicity of the lung. N Engl J Med 1980; 303: 76–86
   PubMed Web of Science ®Google Scholar
• Fahey P J, Utell M J, Mayewski R J, et al. Early diagnosis of bleomycin pulmonary toxicity using bronchoalveolar lavage in dogs. Am Rev Respir Dis 1982; 126: 126–130
   PubMed Web of Science ®Google Scholar
• Marom Z, Weinberg K S, Fanburg B L. Effect of bleomycin on collagenolytic activity of the rat alveolar macrophage. Am Rev Respir Dis 1980; 121: 859–867
   PubMed Web of Science ®Google Scholar
• Weiss S J, LoBuglio A F. Biology of disease. Phagocyte-generated oxygen metabolites and cellular injury. Lab Invest 1972; 47: 5–18
   Google Scholar